{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:10:36Z","timestamp":1790392236007,"version":"4.1.0"},"reference-count":59,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Recovery and Resilience Plan","award":["B53C22004090006"],"award-info":[{"award-number":["B53C22004090006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Patients with primary (PAI) and secondary adrenal insufficiency (SAI) experience bone metabolism alterations, possibly due to excessive replacement. Dual-release hydrocortisone (DR-HC) has shown promising effects on several parameters, but bone metabolism has seldom been investigated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We evaluated the long-term effects of once-daily DR-HC on bone in PAI and SAI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients on immediate-release glucocorticoid therapy were evaluated before and up to 6 years (range, 4-6) after switching to equivalent doses of DR-HC, yielding data on bone turnover markers, femoral and lumbar spine bone mineral density (BMD), and trabecular bone score (TBS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Thirty-two patients (19 PAI, 18 female), median age 52 years (39.4-60.7), were included. At baseline, osteopenia was observed in 38% of patients and osteoporosis in 9%, while TBS was at least partially degraded in 41.4%. Higher body surface area\u2013adjusted glucocorticoid doses predicted worse neck (P &amp;lt; .001) and total hip BMD (P &amp;lt; .001). Longitudinal analysis showed no significant change in BMD. TBS showed a trend toward decrease (P = .090). Bone markers were stable, albeit osteocalcin levels significantly varied. PAI and SAI subgroups behaved similarly, as did patients switching from hydrocortisone or cortisone acetate. Compared with men, women exhibited worse decline in TBS (P = .017) and a similar trend for neck BMD (P = .053).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>After 6 years of chronic DR-HC replacement, BMD and bone markers remained stable. TBS decline is more likely due to an age-related derangement of bone microarchitecture rather than a glucocorticoid effect. Our data confirm the safety of DR-HC replacement on bone health in both PAI and SAI patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jendso\/bvad151","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T06:13:38Z","timestamp":1701929618000},"source":"Crossref","is-referenced-by-count":11,"title":["Effects of Dual-Release Hydrocortisone on Bone Metabolism in Primary and Secondary Adrenal Insufficiency: A 6-Year Study"],"prefix":"10.1210","volume":"8","author":[{"given":"Valeria","family":"Hasenmajer","sequence":"first","affiliation":[{"name":"Department of Experimental Medicine, \u201cSapienza\u201d University of Rome , Rome 00161 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, \u201cSapienza\u201d University of Rome , Rome 00161 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"De Alcubierre","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, \u201cSapienza\u201d University of Rome , Rome 00161 , Italy"},{"name":"Inserm U1052, CNRS UMR5286, Claude Bernard Lyon 1 University, Cancer Research Center of Lyon , Lyon 69373 CEDEX 08 , France {C}%3C!%2D%2D%7C%7CrmComment%7C%7C%3C~show%20%5BAQ%20ID%3DAQ2%5D~%3E%2D%2D%3E"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Sada","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, \u201cSapienza\u201d University of Rome , Rome 00161 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Puliani","sequence":"additional","affiliation":[{"name":"Oncological Endocrinology Unit, IRCCS Regina Elena National Cancer Institute , Rome 00128 , Italy {C}%3C!%2D%2D%7C%7CrmComment%7C%7C%3C~show%20%5BAQ%20ID%3DAQ3%5D~%3E%2D%2D%3E"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Bonaventura","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, \u201cSapienza\u201d University of Rome , Rome 00161 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9091-2809","authenticated-orcid":false,"given":"Marianna","family":"Minnetti","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, \u201cSapienza\u201d University of Rome , Rome 00161 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Tomaselli","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, \u201cSapienza\u201d University of Rome , Rome 00161 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Pofi","sequence":"additional","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital , Oxford OX3 7LE , UK {C}%3C!%2D%2D%7C%7CrmComment%7C%7C%3C~show%20%5BAQ%20ID%3DAQ4%5D~%3E%2D%2D%3E"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2220-9783","authenticated-orcid":false,"given":"Emilia","family":"Sbardella","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, \u201cSapienza\u201d University of Rome , Rome 00161 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Cozzolino","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, \u201cSapienza\u201d University of Rome , Rome 00161 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2682-8266","authenticated-orcid":false,"given":"Daniele","family":"Gianfrilli","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, \u201cSapienza\u201d University of Rome , Rome 00161 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9037-5417","authenticated-orcid":false,"given":"Andrea M","family":"Isidori","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, \u201cSapienza\u201d University of Rome , Rome 00161 , Italy"},{"name":"Centre for Rare Diseases (Endo-ERN accredited), Policlinico Umberto I , Rome 00161 , Italy {C}%3C!%2D%2D%7C%7CrmComment%7C%7C%3C~show%20%5BAQ%20ID%3DAQ5%5D~%3E%2D%2D%3E"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,12,6]]},"reference":[{"issue":"10274","key":"2024010416113106200_bvad151-B1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(21)00136-7","article-title":"Adrenal insufficiency","volume":"397","author":"Husebye","year":"2021","journal-title":"Lancet"},{"key":"2024010416113106200_bvad151-B2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000439329","article-title":"Recent advances in hydrocortisone replacement treatment","volume":"30","author":"Mallappa","year":"2016","journal-title":"Endocr Dev"},{"issue":"2","key":"2024010416113106200_bvad151-B3","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/JOE-20-0066","article-title":"Fixing the broken clock in adrenal disorders: focus on glucocorticoids and chronotherapy","volume":"246","author":"Minnetti","year":"2020","journal-title":"J Endocrinol"},{"issue":"1","key":"2024010416113106200_bvad151-B4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/cen.12603","article-title":"Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy","volume":"82","author":"Johannsson","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2024010416113106200_bvad151-B5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1210\/jc.2011-2036","article-title":"Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy","volume":"97","author":"Koetz","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024010416113106200_bvad151-B6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1507\/endocrj.51.355","article-title":"An assessment of bone mineral density in patients with Addison's disease and isolated ACTH deficiency treated with glucocorticoid","volume":"51","author":"Chikada","year":"2004","journal-title":"Endocr J"},{"issue":"5","key":"2024010416113106200_bvad151-B7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1365-2265.2003.01761.x","article-title":"Long-term follow-up of bone mineral density in Addison's disease","volume":"58","author":"Jodar","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2024010416113106200_bvad151-B8","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1530\/EJE-08-0880","article-title":"Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone","volume":"160","author":"Lovas","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2024010416113106200_bvad151-B9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12020-011-9591-x","article-title":"Clinical outcomes in the management of congenital adrenal hyperplasia","volume":"41","author":"Falhammar","year":"2012","journal-title":"Endocrine"},{"issue":"972","key":"2024010416113106200_bvad151-B10","first-page":"52","article-title":"Bone mineral density is reduced in female but not male subjects with Addison's disease","volume":"107","author":"Florkowski","year":"1994","journal-title":"N Z Med J"},{"issue":"1","key":"2024010416113106200_bvad151-B11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12020-021-02723-z","article-title":"Rate of fracture in patients with glucocorticoid replacement therapy: a systematic review and meta-analysis","volume":"74","author":"Li","year":"2021","journal-title":"Endocrine"},{"issue":"12","key":"2024010416113106200_bvad151-B12","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1210\/jc.2007-0744","article-title":"Fractures and bone mineral density in adult women with 21-hydroxylase deficiency","volume":"92","author":"Falhammar","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024010416113106200_bvad151-B13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12020-017-1380-8","article-title":"Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy","volume":"59","author":"Camozzi","year":"2018","journal-title":"Endocrine"},{"issue":"2","key":"2024010416113106200_bvad151-B14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2796.2011.02352.x","article-title":"Risk of hip fracture in Addison's disease: a population-based cohort study","volume":"270","author":"Bjornsdottir","year":"2011","journal-title":"J Intern Med"},{"issue":"2","key":"2024010416113106200_bvad151-B15","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1210\/clinem\/dgab712","article-title":"Increased prevalence of fractures in congenital adrenal hyperplasia: a Swedish population-based national cohort study","volume":"107","author":"Falhammar","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024010416113106200_bvad151-B16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12020-017-1501-4","article-title":"Skeletal fragility induced by overtreatment of adrenal insufficiency","volume":"59","author":"Falhammar","year":"2018","journal-title":"Endocrine"},{"issue":"8","key":"2024010416113106200_bvad151-B17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41574-020-0341-0","article-title":"Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment","volume":"16","author":"Chotiyarnwong","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2024010416113106200_bvad151-B18","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/jbmr.2176","article-title":"Trabecular bone score: a noninvasive analytical method based upon the DXA image","volume":"29","author":"Silva","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"21","key":"2024010416113106200_bvad151-B19","doi-asserted-by":"crossref","first-page":"14315","DOI":"10.3390\/ijerph192114315","article-title":"Spine fragility fracture prediction using TBS and BMD in postmenopausal women: a Bayesian approach","volume":"19","author":"Ripamonti","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2024010416113106200_bvad151-B20","doi-asserted-by":"crossref","first-page":"996157","DOI":"10.3389\/fendo.2022.996157","article-title":"Trabecular bone score and sclerostin concentrations in patients with primary adrenal insufficiency","volume":"13","author":"Zdrojowy-Welna","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2024010416113106200_bvad151-B21","first-page":"122","article-title":"Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone","volume":"80","author":"Giustina","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024010416113106200_bvad151-B22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s001980050251","article-title":"Bone mineral density in patients with treated Addison's disease","volume":"10","author":"Braatvedt","year":"1999","journal-title":"Osteoporos Int"},{"issue":"4","key":"2024010416113106200_bvad151-B23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1530\/EJE-15-1096","article-title":"Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency","volume":"174","author":"Schulz","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2024010416113106200_bvad151-B24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ando.2014.11.004","article-title":"An observational study on adrenal insufficiency in a French tertiary centre: real life versus theory","volume":"76","author":"Castinetti","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"issue":"9","key":"2024010416113106200_bvad151-B25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1055\/s-0035-1548869","article-title":"Modern hydrocortisone replacement regimens in adrenal insufficiency patients and the risk of adrenal crisis","volume":"47","author":"Rushworth","year":"2015","journal-title":"Horm Metab Res"},{"issue":"3","key":"2024010416113106200_bvad151-B26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2265.2009.03596.x","article-title":"Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency","volume":"72","author":"Bleicken","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024010416113106200_bvad151-B27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fendo.2018.00434","article-title":"Glycometabolic alterations in secondary adrenal insufficiency: does replacement therapy play a role?","volume":"9","author":"Graziadio","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2024010416113106200_bvad151-B28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00223-008-9124-7","article-title":"Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures","volume":"82","author":"Vestergaard","year":"2008","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"2024010416113106200_bvad151-B29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s40618-019-01146-y","article-title":"Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian society of endocrinology expert opinion","volume":"43","author":"Isidori","year":"2020","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2024010416113106200_bvad151-B30","doi-asserted-by":"crossref","first-page":"101379","DOI":"10.1016\/j.beem.2020.101379","article-title":"Autoimmune Addison's disease","volume":"34","author":"Saverino","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"2024010416113106200_bvad151-B31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1210\/jc.2011-1926","article-title":"Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation","volume":"97","author":"Johannsson","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024010416113106200_bvad151-B32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","article-title":"Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial","volume":"6","author":"Isidori","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2024010416113106200_bvad151-B33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s12020-015-0681-z","article-title":"Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease","volume":"51","author":"Giordano","year":"2016","journal-title":"Endocrine"},{"issue":"6","key":"2024010416113106200_bvad151-B34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/cen.14275","article-title":"Systematic review and meta-analysis of the metabolic effects of modified-release hydrocortisone versus standard glucocorticoid replacement therapy in adults with adrenal insufficiency","volume":"93","author":"Bannon","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2024010416113106200_bvad151-B35","doi-asserted-by":"crossref","first-page":"13280","DOI":"10.1038\/s41598-022-13506-5","article-title":"Long-term outcomes of conventional and novel steroid replacement therapy on bone health in primary adrenal insufficiency","volume":"12","author":"Guarnotta","year":"2022","journal-title":"Sci Rep"},{"issue":"3","key":"2024010416113106200_bvad151-B36","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s12020-017-1512-1","article-title":"Bone safety of dual-release hydrocortisone in patients with hypopituitarism","volume":"60","author":"Frara","year":"2018","journal-title":"Endocrine"},{"issue":"1","key":"2024010416113106200_bvad151-B37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0889-8529(02)00062-2","article-title":"Secondary osteoporosis","volume":"32","author":"Stein","year":"2003","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"2024010416113106200_bvad151-B38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12020-023-03318-6","article-title":"Trabecular bone score, bone marrow fat and vertebral fractures in cushing syndrome","volume":"80","author":"Ferrau","year":"2023","journal-title":"Endocrine"},{"issue":"3","key":"2024010416113106200_bvad151-B39","first-page":"129","article-title":"[Guidelines on prevention and treatment of vitamin D deficiency. Italian society for osteoporosis, mineral metabolism and bone diseases (SIOMMMS)]","volume":"63","author":"Adami","year":"2011","journal-title":"Reumatismo"},{"key":"2024010416113106200_bvad151-B40","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvad151","article-title":"Effects of Dual-Release Hydrocortisone on Bone Metabolism in Primary and Secondary Adrenal Insufficiency: a 6-Year Study\u2014Supplemental Materials","author":"Hasenmajer","year":"2023"},{"key":"2024010416113106200_bvad151-B41","doi-asserted-by":"crossref","first-page":"835720","DOI":"10.3389\/fendo.2022.835720","article-title":"Bad to the bone: the effects of therapeutic glucocorticoids on osteoblasts and osteocytes","volume":"13","author":"Gado","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2024010416113106200_bvad151-B42","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s12020-016-1146-8","article-title":"Glucocorticoid-induced osteoporosis: pathophysiological role of GH\/IGF-I and PTH\/VITAMIN D axes, treatment options and guidelines","volume":"54","author":"Mazziotti","year":"2016","journal-title":"Endocrine"},{"key":"2024010416113106200_bvad151-B43","doi-asserted-by":"crossref","first-page":"733611","DOI":"10.3389\/fendo.2021.733611","article-title":"Endogenous glucocorticoid metabolism in bone: friend or foe","volume":"12","author":"Martin","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2024010416113106200_bvad151-B44","doi-asserted-by":"crossref","DOI":"10.1177\/15579883221119363","article-title":"Bone mineral density reference values in 18- to 95-year-old population in lombardy region, Italy","volume":"16","author":"Rondanelli","year":"2022","journal-title":"Am J Mens Health"},{"issue":"1052","key":"2024010416113106200_bvad151-B45","doi-asserted-by":"crossref","first-page":"20140865","DOI":"10.1259\/bjr.20140865","article-title":"Trabecular bone score in healthy ageing","volume":"88","author":"Bazzocchi","year":"2015","journal-title":"Br J Radiol"},{"issue":"8","key":"2024010416113106200_bvad151-B46","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S2213-8587(20)30159-5","article-title":"Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials","volume":"8","author":"Black","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"2024010416113106200_bvad151-B47","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/rheumatology\/kez464","article-title":"Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis","volume":"59","author":"Florez","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"2024010416113106200_bvad151-B48","doi-asserted-by":"crossref","first-page":"350","DOI":"10.5603\/EP.a2019.0022","article-title":"Trabecular bone score (TBS) as a noninvasive and complementary tool for clinical diagnosis of bone structure in endocrine disorders","volume":"70","author":"Halupczok-Zyla","year":"2019","journal-title":"Endokrynol Pol"},{"issue":"3","key":"2024010416113106200_bvad151-B49","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4168\/aair.2019.11.3.343","article-title":"Trabecular bone score is more sensitive to asthma severity and glucocorticoid treatment than bone mineral density in asthmatics","volume":"11","author":"Choi","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"issue":"20","key":"2024010416113106200_bvad151-B50","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.3390\/jcm10204740","article-title":"Age-specific normative values of lumbar spine trabecular bone score (TBS) in Taiwanese men and women","volume":"10","author":"Chuang","year":"2021","journal-title":"J Clin Med"},{"key":"2024010416113106200_bvad151-B51","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2147\/CIA.S358951","article-title":"Age-related changes in trabecular bone score and bone mineral density in Chinese men: a cross-sectional and longitudinal study","volume":"17","author":"Tang","year":"2022","journal-title":"Clin Interv Aging"},{"issue":"4","key":"2024010416113106200_bvad151-B52","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.21037\/qims-22-550","article-title":"Establishing age-adjusted trabecular bone score curves using dual-energy X-ray absorptiometry in Chinese women and men: a cross-sectional study","volume":"13","author":"Wu","year":"2023","journal-title":"Quant Imaging Med Surg"},{"issue":"3","key":"2024010416113106200_bvad151-B53","doi-asserted-by":"crossref","first-page":"207","DOI":"10.7326\/0003-4819-120-3-199402010-00005","article-title":"Effect of glucocorticoid replacement therapy on bone mineral density in patients with addison disease","volume":"120","author":"Zelissen","year":"1994","journal-title":"Ann Intern Med"},{"issue":"4","key":"2024010416113106200_bvad151-B54","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2265.2006.02473.x","article-title":"Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. Timed serum cortisol measurements","volume":"64","author":"Arlt","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024010416113106200_bvad151-B55","doi-asserted-by":"crossref","first-page":"782118","DOI":"10.3389\/fendo.2021.782118","article-title":"When to start and stop bone-protecting medication for preventing glucocorticoid-induced osteoporosis","volume":"12","author":"Hayes","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2024010416113106200_bvad151-B56","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s40618-018-0992-z","article-title":"Bone turnover markers, BMD and TBS after short-term, high-dose glucocorticoid therapy in patients with graves\u2019 orbitopathy: a small prospective pilot study","volume":"42","author":"Censi","year":"2019","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2024010416113106200_bvad151-B57","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/endrev\/bnac031","article-title":"Bone turnover markers: basic biology to clinical applications","volume":"44","author":"Schini","year":"2023","journal-title":"Endocr Rev"},{"issue":"4","key":"2024010416113106200_bvad151-B58","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S2213-8587(22)00012-2","article-title":"Osteoporosis in men","volume":"10","author":"Vilaca","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024010416113106200_bvad151-B59","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bone.2018.08.013","article-title":"Maintenance low dose systemic glucocorticoids have limited impact on bone strength and mineral density among incident renal allograft recipients: a pilot prospective cohort study","volume":"116","author":"Perez-Saez","year":"2018","journal-title":"Bone"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvad151\/54041100\/bvad151.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/8\/1\/bvad151\/55018465\/bvad151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/8\/1\/bvad151\/55018465\/bvad151.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T16:20:41Z","timestamp":1704385241000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvad151\/7459797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvad151","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1]]},"published":{"date-parts":[[2023,12,1]]},"article-number":"bvad151"}}